Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 17 | 2023 | 685 | 3.560 |
Why?
|
| Adolescent Behavior | 10 | 2020 | 243 | 3.500 |
Why?
|
| Receptors, GABA-A | 7 | 2019 | 60 | 3.120 |
Why?
|
| Alcoholism | 15 | 2022 | 220 | 2.410 |
Why?
|
| Peer Group | 9 | 2023 | 138 | 2.280 |
Why?
|
| Juvenile Delinquency | 8 | 2021 | 41 | 2.080 |
Why?
|
| Adolescent | 38 | 2023 | 5035 | 2.030 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2022 | 528 | 1.580 |
Why?
|
| Alcohol Drinking | 10 | 2023 | 490 | 1.420 |
Why?
|
| Child | 24 | 2023 | 2875 | 1.370 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 841 | 1.360 |
Why?
|
| Parenting | 5 | 2023 | 109 | 1.210 |
Why?
|
| Aggression | 6 | 2020 | 75 | 1.120 |
Why?
|
| Temperament | 4 | 2021 | 29 | 1.080 |
Why?
|
| Child Abuse | 2 | 2023 | 60 | 1.050 |
Why?
|
| Genotype | 6 | 2021 | 641 | 1.050 |
Why?
|
| Male | 41 | 2023 | 18870 | 1.010 |
Why?
|
| Humans | 58 | 2023 | 34853 | 1.000 |
Why?
|
| Cannabis | 2 | 2023 | 75 | 0.990 |
Why?
|
| Marijuana Smoking | 3 | 2023 | 82 | 0.980 |
Why?
|
| Female | 41 | 2023 | 19873 | 0.980 |
Why?
|
| Emotions | 7 | 2022 | 204 | 0.890 |
Why?
|
| Goals | 2 | 2013 | 30 | 0.880 |
Why?
|
| Risk Factors | 15 | 2022 | 3414 | 0.780 |
Why?
|
| Internal-External Control | 3 | 2019 | 47 | 0.770 |
Why?
|
| Marijuana Abuse | 4 | 2018 | 83 | 0.760 |
Why?
|
| Self Concept | 2 | 2013 | 136 | 0.720 |
Why?
|
| Negotiating | 1 | 2018 | 26 | 0.640 |
Why?
|
| Interpersonal Relations | 3 | 2017 | 198 | 0.600 |
Why?
|
| Prospective Studies | 9 | 2021 | 1353 | 0.580 |
Why?
|
| Social Behavior Disorders | 1 | 2016 | 5 | 0.570 |
Why?
|
| Parents | 5 | 2023 | 288 | 0.560 |
Why?
|
| Attitude to Health | 1 | 2018 | 311 | 0.550 |
Why?
|
| Adolescent Development | 2 | 2018 | 27 | 0.510 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 229 | 0.490 |
Why?
|
| Personality Development | 1 | 2013 | 7 | 0.480 |
Why?
|
| Affective Symptoms | 4 | 2022 | 55 | 0.480 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2017 | 13 | 0.450 |
Why?
|
| Alleles | 3 | 2019 | 284 | 0.440 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 901 | 0.440 |
Why?
|
| Brain | 3 | 2022 | 1268 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 638 | 0.410 |
Why?
|
| Personality Assessment | 1 | 2011 | 41 | 0.410 |
Why?
|
| Social Adjustment | 1 | 2011 | 26 | 0.410 |
Why?
|
| Michigan | 4 | 2020 | 22 | 0.400 |
Why?
|
| Conduct Disorder | 2 | 2021 | 47 | 0.370 |
Why?
|
| Theory of Mind | 2 | 2020 | 4 | 0.360 |
Why?
|
| Psychometrics | 1 | 2011 | 292 | 0.360 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2021 | 13 | 0.350 |
Why?
|
| Self Efficacy | 2 | 2014 | 173 | 0.300 |
Why?
|
| Asthma | 2 | 2021 | 363 | 0.300 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 2561 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 468 | 0.270 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 260 | 0.270 |
Why?
|
| Impulsive Behavior | 3 | 2021 | 44 | 0.260 |
Why?
|
| Depression | 5 | 2022 | 664 | 0.250 |
Why?
|
| Residence Characteristics | 2 | 2020 | 301 | 0.250 |
Why?
|
| Attitude | 2 | 2018 | 97 | 0.250 |
Why?
|
| Young Adult | 9 | 2020 | 4012 | 0.250 |
Why?
|
| Adult | 13 | 2021 | 11034 | 0.250 |
Why?
|
| Ethanol | 2 | 2023 | 188 | 0.250 |
Why?
|
| Parent-Child Relations | 2 | 2015 | 97 | 0.240 |
Why?
|
| Quality of Life | 3 | 2022 | 459 | 0.230 |
Why?
|
| Models, Psychological | 2 | 2016 | 120 | 0.230 |
Why?
|
| Social Isolation | 1 | 2023 | 27 | 0.230 |
Why?
|
| Anxiety | 4 | 2023 | 705 | 0.230 |
Why?
|
| Alcohol-Related Disorders | 2 | 2018 | 52 | 0.230 |
Why?
|
| New York | 2 | 2014 | 69 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 2 | 2021 | 125 | 0.210 |
Why?
|
| Anxiety Disorders | 3 | 2022 | 281 | 0.210 |
Why?
|
| Intention | 1 | 2022 | 84 | 0.210 |
Why?
|
| Rhinitis | 1 | 2021 | 17 | 0.210 |
Why?
|
| Risk | 3 | 2020 | 256 | 0.200 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 58 | 0.200 |
Why?
|
| Preventive Medicine | 1 | 2021 | 15 | 0.200 |
Why?
|
| Awareness | 1 | 2021 | 59 | 0.200 |
Why?
|
| Child, Preschool | 3 | 2023 | 1318 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 271 | 0.200 |
Why?
|
| Binge-Eating Disorder | 1 | 2020 | 7 | 0.190 |
Why?
|
| Models, Genetic | 2 | 2018 | 149 | 0.190 |
Why?
|
| Commerce | 1 | 2021 | 81 | 0.190 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 23 | 0.180 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 50 | 0.180 |
Why?
|
| Family | 1 | 2020 | 162 | 0.170 |
Why?
|
| Registries | 1 | 2021 | 330 | 0.170 |
Why?
|
| Mental Health | 1 | 2022 | 270 | 0.170 |
Why?
|
| Gender Identity | 2 | 2011 | 93 | 0.170 |
Why?
|
| Schools | 1 | 2020 | 229 | 0.170 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2018 | 18 | 0.170 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 55 | 0.160 |
Why?
|
| Defense Mechanisms | 1 | 2018 | 9 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 254 | 0.160 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 23 | 0.160 |
Why?
|
| Smoking | 3 | 2020 | 903 | 0.160 |
Why?
|
| Inpatients | 2 | 2018 | 72 | 0.160 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 58 | 0.150 |
Why?
|
| Substance Abuse Detection | 2 | 2008 | 27 | 0.150 |
Why?
|
| Depressive Disorder | 1 | 2018 | 166 | 0.150 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 61 | 0.150 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2016 | 4 | 0.140 |
Why?
|
| Arousal | 1 | 2016 | 82 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 80 | 0.140 |
Why?
|
| Reward | 1 | 2016 | 73 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2017 | 287 | 0.140 |
Why?
|
| Socialization | 1 | 2015 | 20 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2018 | 171 | 0.130 |
Why?
|
| Heterozygote | 1 | 2015 | 91 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2019 | 1349 | 0.120 |
Why?
|
| Poverty Areas | 1 | 2014 | 37 | 0.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2014 | 25 | 0.120 |
Why?
|
| Social Control, Informal | 1 | 2013 | 9 | 0.120 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 30 | 0.110 |
Why?
|
| Social Behavior | 1 | 2013 | 124 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 133 | 0.110 |
Why?
|
| Psychotherapy, Group | 2 | 2014 | 18 | 0.110 |
Why?
|
| Character | 1 | 2011 | 1 | 0.100 |
Why?
|
| Hierarchy, Social | 1 | 2011 | 9 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 288 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2014 | 328 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 79 | 0.100 |
Why?
|
| Amygdala | 2 | 2022 | 110 | 0.100 |
Why?
|
| Social Identification | 1 | 2011 | 49 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1033 | 0.100 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 274 | 0.100 |
Why?
|
| Age Factors | 1 | 2013 | 1007 | 0.090 |
Why?
|
| Motivation | 1 | 2013 | 415 | 0.090 |
Why?
|
| Prevalence | 2 | 2020 | 1425 | 0.090 |
Why?
|
| Linkage Disequilibrium | 2 | 2022 | 58 | 0.080 |
Why?
|
| Deception | 1 | 2007 | 5 | 0.080 |
Why?
|
| Middle Aged | 5 | 2020 | 9642 | 0.070 |
Why?
|
| Counseling | 1 | 2007 | 105 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1056 | 0.060 |
Why?
|
| Hospitalization | 1 | 2007 | 370 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 243 | 0.060 |
Why?
|
| United States | 3 | 2020 | 3894 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 14 | 0.050 |
Why?
|
| Empathy | 1 | 2021 | 26 | 0.050 |
Why?
|
| Disease Management | 1 | 2021 | 61 | 0.050 |
Why?
|
| Taxes | 1 | 2021 | 13 | 0.050 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 33 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2021 | 30 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 48 | 0.050 |
Why?
|
| Data Collection | 1 | 2021 | 188 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 54 | 0.050 |
Why?
|
| Sweden | 1 | 2020 | 12 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 165 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2020 | 24 | 0.050 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 72 | 0.050 |
Why?
|
| Canada | 1 | 2020 | 121 | 0.050 |
Why?
|
| Attention | 1 | 2021 | 147 | 0.050 |
Why?
|
| Health Policy | 1 | 2021 | 149 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 871 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Emotional Intelligence | 1 | 2017 | 7 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 882 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 348 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2018 | 347 | 0.040 |
Why?
|
| Sex Factors | 1 | 2018 | 859 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 1961 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2018 | 435 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 22 | 0.030 |
Why?
|
| Negativism | 1 | 2014 | 3 | 0.030 |
Why?
|
| Mass Screening | 1 | 2018 | 427 | 0.030 |
Why?
|
| Haplotypes | 1 | 2014 | 152 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 33 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 253 | 0.030 |
Why?
|
| Educational Status | 1 | 2014 | 295 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2014 | 202 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 608 | 0.030 |
Why?
|
| Social Support | 1 | 2014 | 356 | 0.030 |
Why?
|
| Comorbidity | 1 | 2013 | 606 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2014 | 541 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2007 | 9 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2007 | 37 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 50 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 57 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 84 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 165 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 628 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 964 | 0.020 |
Why?
|
| Aged | 1 | 2007 | 6448 | 0.010 |
Why?
|